Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs (original) (raw)
Small Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents
Carolina Felix
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
Novel N-linked aminopiperidine based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis
Vikas Patil
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Left hand side exploration of novel bacterial topoisomerase inhibitors to improve selectivity against hERG binding
Gajanan Shanbhag, Jayashree Puttur, Anandkumar Raichurkar
ACS Medicinal Chemistry Letters, 2015
View PDFchevron_right
Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing
Anandkumar Raichurkar
ACS Medicinal Chemistry Letters, 2014
View PDFchevron_right
Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis
rinky Rajput
Biochemical Journal, 2020
View PDFchevron_right
Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria
Mark Craighead
Antimicrobial agents and chemotherapy, 2017
View PDFchevron_right
Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors
Shankar Alegaon
Future Journal of Pharmaceutical Sciences
View PDFchevron_right
Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters
Laszlo F Orfi
PLOS ONE, 2018
View PDFchevron_right
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria
bhavesh dhumale
Journal of Medicinal Chemistry, 2021
View PDFchevron_right
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Thuỳ An Hoàng
Bioorganic & medicinal chemistry letters, 2017
View PDFchevron_right
Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in Mycobacterium tuberculosis
Dr. Srinivasan Ramachandran
2020
View PDFchevron_right
Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents
Peter Meinke
ACS Medicinal Chemistry Letters, 2014
View PDFchevron_right
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
Martina Hrast
Journal of Medicinal Chemistry, 2022
View PDFchevron_right
Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads
Janupally Renuka, Perumal Yogeeswari
International journal of antimicrobial agents, 2014
View PDFchevron_right
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)
Marko Anderluh
Journal of Medicinal Chemistry
View PDFchevron_right
Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments
Martina Hrast
Future Medicinal Chemistry, 2019
View PDFchevron_right
Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram Positive Activity and Improved Safety Profile
Michel Enderlin-Paput, Eric Ertel
View PDFchevron_right
Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
Thomas Dougherty
Bioorganic & Medicinal Chemistry, 2014
View PDFchevron_right
De Novo Design of Type II Topoisomerase Inhibitors as Potential Antimicrobial Agents Targeting a Novel Binding Region
Thomas Germe
2021
View PDFchevron_right
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis
Saad Alghamdi
Molecules
View PDFchevron_right
Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis
Sulochana Somasundaram
BMC Structural Biology, 2011
View PDFchevron_right
Targeting Dormant Tuberculosis Bacilli: Results for Molecules with a Novel Pyrimidone Scaffold
Avinash Jain, Dhiman Sarkar
Chemical Biology & Drug Design, 2014
View PDFchevron_right
Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
Peter Madrid
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right
Design, synthesis and characterization of dual inhibitors against new targets FabG4 and HtdX of Mycobacterium tuberculosis
Rupam Biswas
View PDFchevron_right